je.st
news
Shall Means Shall . . . Unless It Doesn't - Amgen Inc., et al. v. Sandoz, Inc.
2015-09-03 03:46:17| Biotech - Topix.net
Addressing issues of first impression related to the Biologics Price Competition and Innovation Act of 2009 , which the U.S. Court of Appeals for the Federal Circuit labeled "a riddle wrapped in a mystery inside an enigma," the Court affirmed dismissal of unfair competition and conversion claims under California law, but reversed the denial of a preliminary injunction. Amgen Inc., et al. v.
Tags: inc
v
et
al
Category:Biotechnology and Pharmaceuticals